Newscast – Page 174 – media

HeartSciences gets CE mark for MyoVista hsECG testing device

MyoVista hsECG testing device has been developed for front-line screening of cardiac disease in both symptomatic and asymptomatic patients.
- Source: medicaldevices
- 618
- August 21, 2017
cardiac CE Company Insight CWT hsECG
New tech “lights up” nerves to identify, reduce accidental damage

A new nerve-illuminating tool has been developed by researchers and they claim it makes nerves stand out from other tissue, lighting it up to help surgeons avoid accidentally injuring nerves and identify nerves in need of repair.
- Source: massdevice
- 493
- August 21, 2017
nerves optical Researches
NeoSync secures $13m in financing with Valiance Life Science Investments and current Investors

NeoSync has announced the completion of its Series D financing round, which included investment from Valiance Life Science Investments, as well as its original investor base totaling $13m.
- Source: patientmonitoring
- 608
- August 17, 2017
Clinical Depression Market Views Series
Camber spine wins FDA nod for Spira interbody fusion device

Camber Spine Technologies' Spira open matrix anterior lumbar interbody fusion device won FDA clearance from the FDA.
- Source: massdevice
- 466
- August 17, 2017
interbody lumbar New Approvals
GSK opens new aluminium salts facility in Scotland

Being set to supply ingredients for around 400 million vaccines a year, a new £44 million aluminium salts facilityhas been officially opened by GlaxoSmithKline in Montrose, Scotland.
- Source: news.open-medical
- 637
- August 17, 2017
aluminium salt Company Insight HIV ingredient respiratory vaccine
MC10 and Shirley Ryan AbilityLab to clinically study BioStampRC System

New treatments for neurodegenerative disease and motion disability will be developed by a research collaboration between digital healthcare solutions provider MC10 and US-based rehabilitation research hospital, Shirley Ryan AbilityLab.
- Source: massdevice
- 507
- August 16, 2017
disability neurodegenerative rehabilitation Researches
VentureMed raises $15m in Series B

Vascular focused device developer VentureMed said today it raised $15 million in a Series B round.
- Source: massdevice
- 510
- August 16, 2017
Company Insight Market Views medical device peripheral artery Series
Atlas awarded £2m grant for infectious disease test

In support of the project in adopting Atlas Genetic's io rapid diagnostic platform into UK sexual health clinics, Innovative UK has awarded them a grant of £2 million.
- Source: news.open-medical
- 448
- August 16, 2017
Company Insight diagnostic infectious
New CUHK study shows early nasopharyngeal cancer detection with EBV DNA

Early asymptomatic nasopharyngeal carcinoma (NPC) will possibly be detectable by plasma Epstein-Barr virus (EBV) DNA analysis, according to a new study carried out by the Chinese University of Hong Kong (CUHK).
- Source: medicaldevice-network
- 531
- August 15, 2017
carcinoma MRI nasopharyngeal Researches
NICE turns down kidney cancer drugs

It is looking unlikely that patients in England and Wales with advanced renal cell carcinoma will be getting routine NHS access to Eisai’s Kisplyx or Eusa Pharma’s Fotivda, after cost regulators issued draft guidelines turning down their use.
- Source: pharmatimes
- 527
- August 15, 2017
cancer kidney Market Views NHS renal

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.